Article
Cancer in Multilineage Mosaic RASopathies due to Pathogenic Variants in HRAS or KRAS: A Systematic Review and Meta-analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Nov 2024
Windrich Jonas, Ney Gina M, Rosenberg Philip S, Kim Jung, Zenker Martin, Stewart Douglas R, Kratz Christian P
Abstract excerpt
PURPOSE: To determine the cancer risk and spectrum in patients with multilineage mosaic RASopathies with pathogenic variants (PV) in HRAS or KRAS. EXPERIMENTAL DESIGN: We conducted a systematic literature review to identify multilineage mosaic RASopathy cases with a PV in HRAS or KRAS to create a retrospective cohort. We calculated cumulative incidence, cancer-free survival, and hazard rates for cancer and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
